Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at ZAR 157.7B, ahead of BioNTech (ZAR 147.1B) and Gilead Sciences (ZAR 130.7B). Figures as of 18 Nov 2026, 21:41 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenZAR 157.7B
Median
ZAR 7.5B
Combined market value
ZAR 14.45T
Countries
5

Market values as of .

All countries
All sectors
Biotech
ZAR
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareZAR 157.7BZAR 4.15TZAR 7,667.98 3.07% down 34% up United States
2BioNTechBNTX · Health CareZAR 147.1BZAR 356.6BZAR 1,438.27 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareZAR 130.7BZAR 3.62TZAR 2,919.05 0.75% down 33% up United States
4argenxARGX · Health CareZAR 60.3BZAR 1.02TZAR 16,259.62 0.66% down 4% up Belgium
5BiogenBIIB · Health CareZAR 52BZAR 642BZAR 4,342.98 0.25% up 49% up United States
6ModernaMRNA · Health CareZAR 44.8BZAR 1.38TZAR 3,399.45 4.84% down 755% up United States
7ImmunovantIMVT · Health CareZAR 15.6BZAR 118.6BZAR 573.00 0.12% down 43% up United States
8QiagenQGEN · Health CareZAR 14.5BZAR 176.8BZAR 856.12 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareZAR 12.3BZAR 284.8BZAR 2,813.33 1.84% down 20% up United States
10RepligenRGEN · Health CareZAR 9.8BZAR 190.7BZAR 2,982.79 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareZAR 8.6BZAR 161.4BZAR 5,447.34 5.62% up 46% up United States
12ExelixisEXEL · Health CareZAR 8.3BZAR 287.9BZAR 1,179.68 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareZAR 6.6BZAR 597.1BZAR 2,760.81 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareZAR 6.2BZAR 178.6BZAR 2,092.46 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareZAR 6BZAR 67.3BZAR 694.26 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareZAR 5.6BZAR 101.2BZAR 829.18 6.48% up 14% up United States
17Bio-TechneTECH · Health CareZAR 4.6BZAR 197.4BZAR 1,256.72 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareZAR 3.6BZAR 110.5BZAR 1,689.62 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareZAR 3.2BZAR 137BZAR 2,009.89 3.88% up 340% up United States
20VaxcytePCVX · Health CareZAR 3BZAR 160BZAR 1,010.90 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareZAR 2.3BZAR 188.7BZAR 1,654.90 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareZAR 1.5BZAR 123.1BZAR 115.74 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareZAR 1.2BZAR 79.6BZAR 491.63 0.11% down 88% up United States
24CG OncologyCGON · Health CareZAR 561.2MZAR 123.4BZAR 1,381.96 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2745 ZAR).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (ZAR 157.7B), BioNTech (ZAR 147.1B) and Gilead Sciences (ZAR 130.7B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 21:41 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of ZAR 14.45T as of 18 Nov 2026, 21:41 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.